Previous chapter:
Chapter 1179 - 926: Do You Dare to Try Charging Up_3
Next chapter:
Chapter 1181 - 927 Why Don’t You Eat_2
PREVIEW
... is a new method to treat diffuse large B-cell lymphoma: Switzerland’s Roche Pharmaceuticals’ Gazyva monoclonal antibody. The total cost of this treatment is about half of that of CAR-T cell therapy, roughly between 600,000 to 1,000,000 RMB, and the treatment effect is also very good.
It is evident that currently, the pharmaceutical industry is still dominated by Western countries. The technological barriers established by these pharmaceutical giants over a century are difficult to overc ...
YOU MAY ALSO LIKE




























